AUTL
Autolus Therapeutics plc
There isn't enough reported data to score AUTL yet.
UNH
UnitedHealth Group Incorporated
UNH's fundamentals are mixed: free cash flow grew 31%, but earnings per share fell 8.5%. At 23x earnings, it's trading right at its usual valuation. Analysts expect strong earnings growth, though they disagree widely on how much.
AUTL Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Weak | |
| Under pressure | |
| Unavailable |
AUTL's profitability and cash flow are currently under pressure. There isn't enough data to rate its revenue and balance sheet.
UNH Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Healthy | |
| Healthy |
UNH's cash flow and balance sheet are currently healthy, and its revenue and profitability are stable.
AUTL PE Valuation
AUTL has no meaningful PE right now: it lost money over the past year.
UNH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 18x | $405 | — |
| Cheap | 19x | $325 | -20% |
| Fair | 23x | $410 | +1.2% |
| Current | 23x | $405 | — |
| Expensive | 30x | $526 | +30% |
Historical ranges are pointers, not guarantees.
UNH's PE is in its fair range at 23x. If earnings grow as analysts expect, today's price would be 18x next year's earnings, in its cheap range.
AUTL Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| Moderate |
Analysts expect AUTL's losses to shrink, with revenue growing.
UNH Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Stable | |
| Improving | |
| Moderate | |
| Low |
Analysts expect UNH's earnings to grow and its profitability to improve, with its revenue holding steady. However, they disagree widely on these estimates.
AUTL Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.97 | -$0.14 |
| Q2 2026 | -$1.06 | -$0.22 |
| Q1 2026 | -$1.09 | -$0.21 |
| Q4 2025 | -$1.08 | -$0.22 |
| Q3 2025 | -$0.83 | +$0.39 |
| Q2 2025 | -$0.84 | +$0.33 |
| Q1 2025 | -$0.88 | +$0.33 |
| Q4 2024 | -$0.86 | +$0.34 |
AUTL is still losing money, but far less than before: $0.97 per share over the past year, against $2.77 at its worst in late 2019.
UNH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $22.65 | +29% |
| Q3 2026 | $17.55 | -8.5% |
| Q2 2026 | $15.58 | -33% |
| Q1 2026 | $13.28 | -44% |
| Q4 2025 | $13.23 | -15% |
| Q3 2025 | $19.17 | +25% |
| Q2 2025 | $23.09 | +53% |
| Q1 2025 | $23.89 | +46% |
| Q4 2024 | $15.51 | -35% |
UNH has the edge over AUTL on earnings quality, reporting a profit while its opponent remains loss making.
AUTL Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $41.2M | +95% |
| Q2 2026 | $45.7M | +118% |
| Q1 2026 | $26.2M | +192% |
| Q4 2022 | $3.8M | +2025% |
| Q3 2022 | $2.4M | +904% |
| Q4 2021 | $180K | -55% |
| Q3 2021 | $236K | -65% |
| Q2 2021 | $1.6M | +461% |
AUTL's revenue has grown year over year for seven quarters in a row: $41M last quarter, up 95% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -106% | +232 points |
| Q2 2026 | -96% | +197 points |
| Q1 2026 | -227% | +499 points |
| Q4 2025 | -298% | N/A |
| Q3 2025 | -338% | N/A |
| Q2 2025 | -293% | N/A |
| Q1 2025 | -726% | N/A |
| Q1 2023 | -2738% | N/A |
AUTL's operating margin was −106% last quarter, up 232 points from the same quarter a year ago.
UNH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $112.7B | -0.4% |
| Q2 2026 | $112B | +0.4% |
| Q1 2026 | $111.7B | +2% |
| Q4 2025 | $113.2B | +12% |
| Q3 2025 | $113.2B | +12% |
| Q2 2025 | $111.6B | +13% |
| Q1 2025 | $109.6B | +9.8% |
| Q4 2024 | $100.8B | +6.8% |
UNH has the edge over AUTL on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 5.8% | +2 points |
| Q2 2026 | 7.1% | +2.5 points |
| Q1 2026 | 8.1% | -0.3 points |
| Q4 2025 | 0.3% | -7.4 points |
| Q3 2025 | 3.8% | -4.8 points |
| Q2 2025 | 4.6% | -3.4 points |
| Q1 2025 | 8.3% | +0.4 points |
| Q4 2024 | 7.7% | -0.4 points |
UNH has the edge over AUTL on profitability, with a higher operating margin.
AUTL Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$19.8M | +$52.5M |
| Q2 2026 | -$26M | +$54.1M |
| Q1 2026 | -$68M | +$15.8M |
| Q4 2025 | -$66.4M | -$17.4M |
| Q3 2025 | -$72.3M | +$14M |
| Q2 2025 | -$80.1M | -$28.1M |
| Q1 2025 | -$83.8M | -$42.8M |
| Q4 2024 | -$49M | -$22.7M |
AUTL has burned cash in almost every quarter: −$180M over the past year, against −$285M the year before.
UNH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $4.3B | -16% |
| Q2 2026 | $10.3B | +63% |
| Q1 2026 | $8.1B | +79% |
| Q4 2025 | $160M | -89% |
| Q3 2025 | $5.1B | -61% |
| Q2 2025 | $6.3B | +6.9% |
| Q1 2025 | $4.6B | +1037% |
| Q4 2024 | $1.5B | +$7.6B |
UNH has the edge over AUTL on cash generation, producing positive trailing cash flow while its opponent burns cash.
AUTL Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | +44.8K shares |
| 1 year | 0% | +62.2K shares |
| 3 years | +53% | +92.3M shares |
| 5 years | +276% | +195M shares |
| Available history | +434% | +216M shares |
AUTL has 266M diluted shares, about the same as a year ago.
| Quarter | Spent |
|---|---|
| Q2 2023 | — |
| Q1 2023 | — |
| Q4 2022 | — |
| Q3 2022 | — |
| Q2 2022 | — |
| Q1 2022 | — |
| Q4 2021 | — |
| Q3 2021 | — |
UNH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -4M shares |
| 1 year | -0.7% | -6M shares |
| 3 years | -3.6% | -34M shares |
| 5 years | -5.5% | -53M shares |
| Available history | -6.6% | -64M shares |
UNH has the edge over AUTL on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $3.4B |
| Q2 2026 | $1.6B |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | $2.5B |
| Q1 2025 | $3B |
| Q4 2024 | $5B |
UNH spent $5B buying back its own shares over the past year, down 52% from the year before.
AUTL Net Leverage
AUTL's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
UNH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.7x | Healthy |
| Q2 2026 | 1.7x | Healthy |
| Q1 2026 | 2.2x | Moderate |
| Q4 2025 | 2.3x | Moderate |
| Q3 2025 | 1.7x | Healthy |
| Q2 2025 | 1.5x | Healthy |
| Q1 2025 | 1.3x | Healthy |
| Q4 2024 | 1.4x | Healthy |
UNH's net debt is about 1.7 years of its operating earnings (EBITDA), about the same as a year ago.
AUTL Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 35.0 | Neutral |
| Stochastic | 6.1 | Oversold |
AUTL's weekly RSI is 35 (neutral) and its Stochastic is 6 (oversold).
UNH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 56.4 | Neutral |
| Stochastic | 60.0 | Neutral |
UNH's weekly RSI is 56 (neutral) and its Stochastic is 60 (neutral).
AUTL PE vs Healthcare Sector
AUTL has no meaningful PE right now: it lost money over the past year.
UNH PE vs Healthcare Sector
| Metric | UNH | Sector median | Relative |
|---|---|---|---|
| PE | 23x | 26x | 11% below |
| PE % | 47 | 29 | 18 pts above |
UNH is trading at 23x earnings, a 11% discount to the Healthcare sector's median of 26x.
AUTL Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1.57 | 24% below |
| 20 week MA | $1.76 | 32% below |
| 50 week MA | $1.63 | 27% below |
| 100 week MA | $1.73 | 31% below |
| 200 week MA | $2.71 | 56% below |
AUTL is in a downtrend: it's below all five of its weekly moving averages, and 56% below its 200-week average.
UNH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $394.2 | 2.8% above |
| 20 week MA | $400.5 | 1.2% above |
| 50 week MA | $361.2 | 12% above |
| 100 week MA | $376.0 | 7.8% above |
| 200 week MA | $446.6 | 9.3% below |
UNH has the edge over AUTL on trend strength, trading above more of its moving averages.
AUTL Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $13.6 | $8.90 | -35% |
| 2021 | $8.90 | $5.46 | -39% |
| 2022 | $5.46 | $1.86 | -66% |
| 2023 | $1.86 | $6.44 | +246% |
| 2024 | $6.44 | $2.26 | -65% |
| 2025 | $2.26 | $1.67 | -26% |
| 2026 YTD | $1.67 | $1.19 | -29% |
AUTL's yearly returns have swung widely, from +246% in 2023 to −66% in 2022. It's down 29% so far in 2026.
UNH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $296.0 | $340.8 | +15% |
| 2021 | $340.8 | $495.4 | +45% |
| 2022 | $495.4 | $531.3 | +7.3% |
| 2023 | $531.3 | $526.5 | -0.9% |
| 2024 | $526.5 | $510.0 | -3.1% |
| 2025 | $510.0 | $331.8 | -35% |
| 2026 YTD | $331.8 | $405.1 | +22% |
UNH has the edge over AUTL on returns for 2026, with the stronger performance.